Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $4.92M | $0.00 | -$29.63M | -$35.65M | -$7.97 | N/A | -100.00% | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $19.04M | $0.00 | -$17.74M | -$18.50M | -$0.48 | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| IMA | IMAGENEBIO INC | $33.06M | $0.00 | -$28.07M | -$30.74M | -$7.68 | -100.00% | N/A | N/A | N/A | |||
| ACXP | ACURX PHARMACEUTICALS INC | $8.16M | $0.00 | -$10.00M | -$10.00M | -$10.69 | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| ATYR | ATYR PHARMA INC | $72.45M | $0.00 | -$62.26M | -$63.41M | -$0.80 | -100.00% | -100.00% | N/A | N/A | |||
| MRSN | MERSANA THERAPEUTICS INC | $42.22M | $34.77M | -$65.59M | -$74.04M | -$14.62 | 16.14% | 83.02% | N/A | N/A | 2025-11-11 | ||
| CANF | CAN-FITE BIOPHARMA LTD | $4.95M | $560.00k | -$8.74M | -$8.80M | $0.00 | -16.04% | -20.34% | N/A | N/A | |||
| NRXP | NRX PHARMACEUTICALS INC | $52.42M | $0.00 | -$33.79M | -$33.79M | -$2.24 | N/A | N/A | N/A | N/A | |||
| SGMO | SANGAMO THERAPEUTICS INC | $165.94M | $81.71M | -$55.42M | -$64.59M | -$0.29 | 565.52% | -6.02% | N/A | N/A | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $27.08M | $868.00k | -$34.61M | -$50.95M | -$11.94 | -63.88% | N/A | N/A | N/A | |||
| PSTV | PLUS THERAPEUTICS INC | $74.90M | $5.26M | -$16.33M | -$20.58M | -$1.70 | -8.16% | 28.67% | N/A | N/A | |||
| GRI | GRI BIO INC | $4.23M | $0.00 | -$10.02M | -$11.92M | $3.81 | N/A | N/A | -99.72% | N/A | |||
| FGEN | FIBROGEN INC | $44.48M | -$72.84M | $2.18M | -$2.07M | -$0.38 | N/A | N/A | N/A | N/A | |||
| TVRD | TVARDI THERAPEUTICS INC | $39.57M | $6.58M | -$13.45M | -$20.89M | -$16.18 | -34.23% | -22.82% | N/A | N/A | 2025-11-13 | ||
| CING | CINGULATE INC | $20.68M | $0.00 | -$17.32M | -$17.96M | -$4.10 | N/A | N/A | N/A | N/A | |||
| JSPR | JASPER THERAPEUTICS INC | $31.69M | $0.00 | -$88.84M | -$90.92M | -$6.03 | N/A | N/A | N/A | N/A | |||
| MDCX | MEDICUS PHARMA LTD | $40.98M | $0.00 | -$16.73M | -$16.51M | -$1.34 | N/A | N/A | N/A | N/A | 2025-11-21 | ||
| LSTA | LISATA THERAPEUTICS INC | $20.12M | $1.00M | -$20.10M | -$19.31M | -$2.30 | N/A | N/A | N/A | N/A | 2025-11-06 | ||
| ENLV | ENLIVEX THERAPEUTICS LTD | $23.86M | $0.00 | -$14.99M | -$13.10M | -$0.58 | N/A | N/A | N/A | N/A | 2025-12-01 | ||
| SKYE | SKYE BIOSCIENCE INC | $46.79M | $0.00 | -$41.90M | -$42.37M | -$1.07 | N/A | N/A | N/A | N/A | |||
| IMUX | IMMUNIC INC | $69.28M | $0.00 | -$96.19M | -$96.40M | -$0.95 | N/A | N/A | N/A | N/A | 2025-11-06 | ||
| MYO | MYOMO INC | $32.62M | $40.76M | -$7.41M | -$9.32M | -$0.22 | 93.07% | 59.13% | N/A | N/A | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $9.05M | $0.00 | -$7.09M | -$7.09M | -$3.25 | N/A | N/A | N/A | N/A | |||
| PASG | PASSAGE BIO INC | $21.30M | $0.00 | -$55.01M | -$56.86M | -$18.16 | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| ACET | ADICET BIO INC | $57.07M | $0.00 | -$107.56M | -$117.32M | -$1.29 | N/A | N/A | N/A | N/A | |||
| PMN | PROMIS NEUROSCIENCES INC | $21.24M | $0.00 | -$8.43M | -$8.43M | -$0.21 | N/A | N/A | N/A | N/A | 2025-11-12 | ||
| MBRX | MOLECULIN BIOTECH INC | $14.45M | $0.00 | -$26.43M | -$26.55M | -$3.52 | N/A | N/A | N/A | N/A | |||
| FEMY | FEMASYS INC | $22.75M | $1.70M | -$18.54M | -$21.11M | -$0.91 | 61.97% | N/A | N/A | N/A | 2025-11-06 | ||
| VNRX | VOLITIONRX LTD | $46.37M | $1.32M | -$21.60M | -$23.32M | -$0.25 | 35.10% | 125.09% | N/A | N/A | 2025-11-13 | ||
| TIL | INSTIL BIO INC | $104.23M | $0.00 | -$74.48M | -$84.51M | -$12.92 | N/A | N/A | N/A | N/A | |||
| MTVA | METAVIA INC | $24.20M | $0.00 | -$18.47M | -$18.49M | -$1.49 | N/A | N/A | N/A | N/A | |||
| CTSO | CYTOSORBENTS CORP | $46.64M | $34.54M | -$13.83M | -$15.84M | -$0.28 | 12.77% | 3.94% | N/A | N/A | 2025-11-06 | ||
| BMEA | BIOMEA FUSION INC | $79.74M | $0.00 | -$107.23M | -$112.09M | -$3.02 | N/A | N/A | N/A | N/A | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $11.19M | $0.00 | -$24.46M | -$26.82M | -$21.31 | N/A | N/A | N/A | N/A | |||
| BOLT | BOLT BIOTHERAPEUTICS INC | $9.35M | $4.17M | -$47.13M | -$50.71M | -$26.46 | -62.68% | N/A | N/A | N/A | |||
| RNXT | RENOVORX INC | $37.75M | $662.00k | -$11.00M | -$10.66M | -$0.38 | N/A | N/A | N/A | N/A | 2025-11-17 | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $246.29M | $0.00 | -$223.22M | -$236.91M | -$1.11 | -100.00% | N/A | N/A | N/A | |||
| ATOS | ATOSSA THERAPEUTICS INC | $106.95M | $0.00 | -$28.70M | -$28.72M | -$0.23 | N/A | N/A | N/A | N/A | 2025-11-17 | ||
| TCRX | TSCAN THERAPEUTICS INC | $64.41M | $6.96M | -$130.55M | -$136.78M | -$1.09 | -42.94% | N/A | N/A | N/A | |||
| SLN | SILENCE THERAPEUTICS PLC | $294.45M | $27.37M | -$73.76M | -$79.40M | N/A | 21.64% | 73.57% | N/A | N/A | 2025-11-13 | ||
| EKSO | EKSO BIONICS HOLDINGS INC | $13.77M | $14.75M | -$8.70M | -$10.43M | -$5.68 | -16.59% | 7.34% | N/A | N/A | |||
| ANVS | ANNOVIS BIO INC | $39.75M | $0.00 | -$30.26M | -$30.26M | -$1.99 | N/A | N/A | N/A | N/A | |||
| FBRX | FORTE BIOSCIENCES INC | $128.06M | $0.00 | -$42.40M | -$42.45M | -$3.69 | N/A | N/A | N/A | N/A | |||
| NEUP | NEUPHORIA THERAPEUTICS INC | $10.37M | $10.23M | -$114.45k | -$241.59k | -$0.15 | N/A | 216.97% | N/A | N/A | |||
| HUMA | HUMACYTE INC | $229.64M | $818.00k | -$40.80M | -$58.66M | -$0.45 | N/A | N/A | N/A | N/A | 2025-11-07 | ||
| NAKA | KINDLY MD INC | $6.15M | $2.24M | -$5.19M | -$5.47M | -$0.86 | -27.67% | N/A | N/A | N/A | 2025-12-03 | ||
| NKTX | NKARTA INC | $138.50M | $0.00 | -$97.90M | -$109.24M | -$1.47 | N/A | N/A | N/A | N/A | |||
| AVXL | ANAVEX LIFE SCIENCES CORP | $627.88M | $0.00 | -$48.29M | -$48.17M | -$0.57 | N/A | N/A | N/A | N/A | 2025-12-22 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.